Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice
Annals of Clinical and Translational Neurology · 2026-11 · 13 (11) · 2303-2308
DOI: 10.1002/acn3.70397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 17.04.2026. Verfasst von Marika Pane und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Carbamates, Hypertriglyceridemia, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy.
Methods
The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean 10.1 years, SD: 3.2 years) and with a follow up between 6.0 and 14.6 months (mean 10.6 months; SD 2.6 months).
Results
Platelets count decrease and triglyceride levels increase were the most common adverse events, followed by diarrhea. A dose reduction was needed in 38 of the 90 boys following thrombocytopenia ( n = 34), diarrhea ( n = 2), and hypertriglyceridemia ( n = 4), with two of the boys presenting both thrombocytopenia and hypertriglyceridemia. Eleven of the 38 boys with initial dose reduction (10 with thrombocytopenia and 1 with hypertriglyceridemia) required an additional dose reduction for persistence of values outside the threshold, with one of them discontinuing treatment because of persistent hypertriglyceridemia even with the lowest dose.
Interpretation
Our results confirm the safety profile observed in the pivotal study providing further evidence of the management of the drug in a real‐world setting. In our experience, treatment with givinostat was well managed by maintaining a strict monitoring. This was facilitated by allowing families to perform blood tests in local labs, reducing the stress and burden of frequent visits to the hospital.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- The NEMO Center in Milan, Neurorehabilitation Unit, University of Milan, ASST Niguarda Hospital, Milan, Italy.
- Center of Translational and Experimental Myology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
ORCID-Profile: Adele D'Amico, Luca Bello, Michele Tosi, Elena Pegoraro
Zitieren
APA
Pane, M., Capasso, A., Arpaia, C., D'Amico, A., Albamonte, E., Trucco, F., Sframeli, M., Masson, R., Magri, F., Bello, L., Venditti, R., Dosi, C., Catteruccia, M., Tosi, M., Bruno, C., Messina, S., Comi, G., Pegoraro, E., Sansone, V. A., & Mercuri, E. (2026). Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice. Annals of Clinical and Translational Neurology, 13(11), 2303-2308. https://doi.org/10.1002/acn3.70397
Vancouver
Pane M, Capasso A, Arpaia C, D'Amico A, Albamonte E, Trucco F, et al. Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice. Annals of Clinical and Translational Neurology. 2026;13(11):2303-2308. doi:10.1002/acn3.70397
BibTeX
@article{Pane2026,
author = {Pane, Marika and Capasso, Anna and Arpaia, Chiara and D'Amico, Adele and Albamonte, Emilio and Trucco, Federica and Sframeli, Maria and Masson, Riccardo and Magri, Francesca and Bello, Luca and Venditti, Romina and Dosi, Claudia and Catteruccia, Michela and Tosi, Michele and Bruno, Claudio and Messina, Sonia and Comi, Giacomo and Pegoraro, Elena and Sansone, Valeria A and Mercuri, Eugenio},
title = {Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
volume = {13},
number = {11},
pages = {2303--2308},
doi = {10.1002/acn3.70397}
}
EUVIMED